UTHR Nov 2024 280.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:50PM EDT. Market open.
| Previous close | 30.65 |
| Open | 30.65 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 280.00 |
| Expiry date | 2024-11-15 |
| Day's range | 30.65 - 30.65 |
| Contract range | N/A |
| Volume | |
| Open interest | 8 |
Investor's Business DailyWhy United Therapeutics, An IBD 50 Stock, Has Surged 36% Over Nine Weeks
There are two types of biotech stocks, says Dewey Steadman, who heads up investor relations for United Therapeutics.
GuruFocus.comInsider Sale: Director Christopher Causey Sells Shares of United Therapeutics Corp (UTHR)
United Therapeutics Corp, a biotechnology firm, focuses on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening conditions. Over the past year, Christopher Causey has engaged in multiple transactions, selling a total of 12,640 shares and purchasing none. Shares of United Therapeutics Corp were priced at $304.18 on the day of the sale.
GuruFocus.comInsider Sale: Director Judy Olian Sells Shares of United Therapeutics Corp (UTHR)
Director Judy Olian sold 1,700 shares of United Therapeutics Corp (NASDAQ:UTHR) on June 17, 2024, as reported in a recent SEC Filing.
© 2024 Yahoo. All rights reserved.